Diadexus, Inc. Share Price

DDXSQ

US25245P2056

Pharmaceuticals

Delayed OTC Markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

17/21/17	Diadexus, Inc. Went Out of Business	CI
08/18/08	Motion for Asset Sale Approved for Diadexus, Inc.	CI

Diadexus, Inc. is a diagnostics company. The Company is engaged in developing and commercializing products that deliver healthcare providers with relevant information to assist in the management of patients throughout the course of cardiac disease. Its capabilities include manufacturing, assay development, Food and Drug Administration (FDA) regulatory clearance, and marketing and selling products. Its commercially-available products consist of two FDA-cleared tests to measure Lp-PLA2: the PLAC Test ELISA Kit (the PLAC ELISA Test) and the PLAC Test for Lp-PLA2 Activity (the PLAC Activity Test). Its other products include proADM; proET-1, which aids in predication of heart failure, and proANP, which aids in predication of heart failure. The Company sells its diagnostic products to laboratories and promotes these products to the laboratories' sales representatives, as well as directly to healthcare providers.

Employees

Sector

Pharmaceuticals

More about the company

Stock Market
Stocks
DDXSQ Stock

As early as today, start finding the best investment opportunities!

Market Cap	49.2T 43.96T 40.38T 36.67T 68.86T 46.61L 70.59T 5L 2L 24.6L 2L 2L 77.97L	P/E 2014	-3.26x	P/E 2015	-1.14x
Enterprise Value	52.9L 47.26L 43.41L 39.43L 74.04L 50Cr 75.9L 5.18Cr 2.08Cr 26Cr 1.99Cr 1.94Cr 84Cr	EV / Sales 2014	1.05x	EV / Sales 2015	0.77x
Free-Float	100%	Yield 2014 *	-	Yield 2015	-

17/21/17	Diadexus, Inc. Went Out of Business	CI
08/18/08	Motion for Asset Sale Approved for Diadexus, Inc.	CI
09/18/09	Motion for Asset Sale Filed by Diadexus, Inc.	CI
01/16/01	Diazyme Laboratories, Inc. completed the acquisition of operational assets from Diadexus, Inc. (OTCPK:DDXS.Q).	CI
29/16/29	Motion for Asset Sale Approved for Diadexus, Inc.	CI
29/16/29	General Atomics Corp. entered into purchase agreement to acquire operational assets from Diadexus, Inc. (OTCPK:DDXS.Q) for $4.8 million.	CI
20/16/20	Cleveland HeartLab, Inc. cancelled the acquisition of operational assets from Diadexus, Inc. (OTCPK:DDXS.Q).	CI
07/16/07	Motion for Asset Sale Filed by Diadexus, Inc.	CI
07/16/07	Cleveland HeartLab, Inc. agreed to acquire operational assets from Diadexus, Inc. (OTCPK:DDXS.Q) for $7 million.	CI
13/16/13	Diadexus, Inc. Filed for Bankruptcy	CI
10/16/10	Diadexus, Inc. Announces Resignation of Leone Patterson as Chief Financial Office	CI
23/16/23	Diadexus, Sonic Healthcare USA Sign National Agreement for PLAC Activity Test	CI
30/16/30	Diadexus, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2016	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DIADEXUS, INC.	-.--%	-.--%	-	-	410
ELI LILLY AND COMPANY	-0.11%	+10.18%	+63.34%	+142.88%	1,25700Cr
JOHNSON & JOHNSON	-1.62%	-0.05%	+40.93%	+77.16%	65TCr
ABBVIE INC.	-0.98%	-0.26%	+31.17%	+99.64%	51TCr
ROCHE HOLDING AG	-1.56%	-1.39%	+51.02%	+64.18%	39TCr
MERCK & CO., INC.	-2.49%	+2.89%	+68.26%	+40.66%	37TCr
NOVARTIS AG	-0.02%	+3.15%	+32.47%	+55.33%	30TCr
ASTRAZENECA PLC	-0.72%	+7.05%	+10.34%	+32.79%	29TCr
AMGEN INC.	-0.90%	+3.74%	+54.56%	+73.02%	25TCr
GILEAD SCIENCES, INC.	-1.68%	+5.53%	+39.80%	+106.17%	21TCr
Average	-0.65%	+4.14%	+43.54%	+76.87%	42.27TCr
Weighted average by Cap.	-0.25%	+5.30%	+47.77%	+91.67%

	2014	2015
Net sales	2.61Cr 2.33Cr 2.14Cr 1.95Cr 3.65Cr 247.35Cr 3.75Cr 26Cr 10Cr 130.55Cr 9.8Cr 9.59Cr 413.8Cr	1.79Cr 1.6Cr 1.47Cr 1.33Cr 2.5Cr 169.41Cr 2.57Cr 18Cr 7.05Cr 89Cr 6.71Cr 6.57Cr 283.41Cr
Net income	-84.67L -75.64L -69.48L -63.11L -1.19Cr -80Cr -1.21Cr -8.29Cr -3.34Cr -42Cr -3.18Cr -3.11Cr -134.18Cr	-71.66L -64.02L -58.81L -53.41L -1Cr -68Cr -1.03Cr -7.02Cr -2.82Cr -36Cr -2.69Cr -2.63Cr -113.56Cr
Net Debt	-2L -2L -2L -1L -3L -1.88Cr -3L -19.4L -8L -99L -7L -7L -3.14Cr	52.41L 46.82L 43.01L 39.06L 73.35L 50Cr 75.2L 5.13Cr 2.07Cr 26Cr 1.97Cr 1.93Cr 83Cr

Diadexus, Inc. Share Price

Stocks

DDXSQ

US25245P2056

Pharmaceuticals

Valuation: Diadexus, Inc.

Latest news: Diadexus, Inc.

Diagnostic & Testing Substances Manufacturers

Financials

Company Profile